Search
Agency CommentsCAGW Submits Comment to FDA on IQOS 3 Modified Risk Tobacco Product Application
IQOS 3 is a tobacco harm reduction product and should receive a Modified Risk Tobacco Product designation quickly
Agency CommentsCAGW Comments to the NAIC Concerning Pharmacy Benefit Managers
CAGW writes comments to the National Association of Insurance Commissioners regarding draft model legislation concerning pharmacy benefit managers.
Agency CommentsCAGW Submits Comments to FDA on Drug Importation Proposed Rule
Comments to the Food and Drug Administration on Proposed Rule for Importing Drugs from Canada
Agency CommentsComment to FDA on Draft Guidance for Importation of Certain Drugs
Citizens Against Government Waste's Comment on Draft Guidance: Importation of Certain Food and Drug Administration-Approved Human Prescription Drugs, Including Biological Products
Agency CommentsComment to CMS - Medicaid Fiscal Accountability Regulation (MFAR)
Medicaid is a federal and state funded program but is administered by the states.
Agency CommentsCAGW Submits Comments to CMS on Transparency Rule
CAGW has long advocated for more market forces to be used in the U.S. healthcare system.
Agency CommentsComment to CMS - Do Not Adopt Destructive Price Controls in Medicare Part B
November 16, 2018 Centers for Medicare and Medicaid Services Department of Health and Human Services P.O. Box 8013 Baltimore, MD 21244-1850 Attention:
Agency CommentsComment to CMS - Pharmaceuticals DTC Advertising
November 13, 2018 Centers for Medicare and Medicaid Services Department of Health and Human Services P.O. Box 8013 Baltimore, MD 21244-1850 Attention: Docket CMS-4187-P
